BHRC BLOG AOD-9604 Safety Profile: What Clinical Trials Show AOD-9604 Safety Profile: What Clinical Trials Show When considering any peptide therapy, understanding its safety profile is paramount
They found a half-life of under 30 minutes post-injection, with bioavailability after intramuscular administration at 14 to 19 percent for rats and 45 to 51 percent for dogs
Retrieved 22 April 2022, from Zeuschner, C.L., Hokin, B.D., Marsh, K.A., Saunders, A.V., Reid, M.A
In females, it triggers the final maturation of pre-ovulatory ovarian follicles, promoting ovulation
You will only need to take the Wegovy pill for as long as it takes you to reach your target weight, but you can choose to continue taking it to maintain your weight loss until youre ready to stop